ERBB2 and breast cancer: According to the expression of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2) proteins, BC can be divided into several subtypes, and each lead to certain therapeutic sensitivities and prognoses (Heer et al., 2020).